Ritivel is an AI-native workspace for regulatory and medical writing teams at life sciences companies. Its AI agents draft dense regulatory documents - CTDs, CSRs, INDs, and BLAs - directly in Microsoft Word, following FDA formatting rules and pulling from a company's own clinical data and prior submissions, with every claim cited back to its source. The goal is to compress work that normally takes weeks of manual synthesis into minutes, helping drugs reach patients sooner.
Synthio Labs builds clinical-grade voice and agentic AI for life sciences customer engagement. Its platform helps pharma field teams, medical affairs, and patient-support orgs run compliant, continuous conversations across HCPs and patients, powered by a clinical reasoning engine that ingests FDA labels and real-world evidence.
Jake Saper is a General Partner at Emergence Capital, the San Francisco-based venture firm that backed Zoom, Salesforce, and Veeva before the rest of the world caught on. Over a decade at Emergence, he has become one of the loudest and most credible voices on AI-native services — companies that combine human expertise with AI to displace the $200B consulting industry. His 2024 essay 'The Death of Deloitte' earned him a cease-and-desist from Deloitte and a loyal readership of founders rebuilding professional services from scratch. A Yale and Stanford-trained operator-turned-investor, he grew up in Austin watching serial-entrepreneur parents build companies, started his own career selling rocks door-to-door from a Radio Flyer wagon, and today holds board seats at category-defining enterprise companies while maintaining a side career as a self-described 'mediocre guitar player.'